OCT 19TH
7:00PM- 8:30PM
BERLIN, GERMANY
UNDERSTANDING
THE CHALLENGE
Theranostics is revolutionizing the future of oncology by combining the power of diagnostic imaging and targeted therapy in one dynamic approach.
This approach helps patients with limited treatment options, particularly those in advanced stages, by targeting specific tumor biomarkers and providing real-time insights into treatment effectiveness.
With theranostics, we are witnessing an exciting leap forward in oncology, transforming patient care and offering the potential for life-saving outcomes. This rapidly growing field is poised for breakthroughs that could redefine the future of cancer treatment.
However, despite its immense potential, awareness among clinical oncologists remains limited, and logistical challenges still hinder its widespread adoption.
About MEDSIR
A new model for collaborative research in clinical oncology
MEDSIR has more than a decade of experience developing strategic clinical trials in oncology, by combining the medical knowledge of our KOLs network, with a multidisciplinary expertise in clinical trials. Our innovative strategies lead to the generation of groundbreaking collaborative trials that respond to unmet clinical need while complementing the internal development program of your drug.
"
WE WANT TO IMPROVE THE LIVES OF CANCER PATIENTS BY ENSURING THEY HAVE ACCESS TO THE BEST TREATMENT OPTIONS FOR THEIR DISEASE.
